Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, EBV-positive cutaneous T-cell lymphoproliferative disorder, composed of CD8 positive cytotoxic T-lymphocytes. It affects children, almost exclusively in Latin America and Asia. Patients present with papulovesicular skin lesions, clinically resembling hydroa vacciniforme, in areas of sun-exposed skin.
2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
3 publications have been identified in PubMed for hydroa vacciniforme-like lymphoma. Kisho has analyzed 2 by research type. Research spans Case Report / Case Series (100%).
Mariano-Rodriguez C (2024). [PMID: 39351038](https://pubmed.ncbi.nlm.nih.gov/39351038/). *Cureus*. [Case Report / Case Series]
Xu KR (2024). [PMID: 39732504](https://pubmed.ncbi.nlm.nih.gov/39732504/). *BMJ Case Rep*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:40 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning hydroa vacciniforme-like lymphoma
Updated Apr 24, 2026
A recent publication discusses the clinical features and diagnostic criteria for hydroa vacciniforme, a rare photosensitive condition. The article emphasizes the importance of early recognition and management to improve patient outcomes.